Massachusetts Medicaid system said it wants the right to refuse to reimburse for some drugs, citing rising costs. Investors should take note because it could imperil smaller drug companies, and other states could follow suit.
from WSJ.com: Markets http://ift.tt/2x0ufeM
via https://ifttt.com/ IFTTT
No comments:
Post a Comment